{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T06:59:25Z","timestamp":1779260365724,"version":"3.51.4"},"reference-count":10,"publisher":"Centers for Disease Control MMWR Office","issue":"30","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["MMWR Morb. Mortal. Wkly. Rep."],"DOI":"10.15585\/mmwr.mm7130a4","type":"journal-article","created":{"date-parts":[[2022,7,28]],"date-time":"2022-07-28T11:11:16Z","timestamp":1659006676000},"page":"971-976","source":"Crossref","is-referenced-by-count":27,"title":["Safety Monitoring of COVID-19 mRNA Vaccine Second Booster Doses Among Adults Aged \u226550 Years \u2014 United States, March 29, 2022\u2013July 10, 2022"],"prefix":"10.15585","volume":"71","author":[{"given":"Anne M.","family":"Hause","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Baggs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paige","family":"Marquez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Winston E.","family":"Abara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jane","family":"Baumblatt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Phillip G.","family":"Blanc","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John R.","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brandon","family":"Hugueley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Casey","family":"Parker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tanya R.","family":"Myers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julianne","family":"Gee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tom T.","family":"Shimabukuro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David K.","family":"Shay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"6224","published-online":{"date-parts":[[2022,7,29]]},"reference":[{"key":"key-10.15585\/mmwr.mm7130a4-202207280706-R1","unstructured":"Food and Drug Administration. Pfizer-BioNTech COVID-19 vaccine letter of authorization (reissued). Silver Spring, MD: US Department of Health and Human Services, Food and Drug Administration; 2022. https:\/\/www.fda.gov\/media\/150386\/download"},{"key":"key-10.15585\/mmwr.mm7130a4-202207280706-R2","unstructured":"Food and Drug Administration. Moderna COVID-19 vaccine letter of authorization (reissued). Silver Spring, MD: US Department of Health and Human Services, Food and Drug Administration; 2021. https:\/\/www.fda.gov\/media\/144636\/download"},{"key":"key-10.15585\/mmwr.mm7130a4-202207280706-R3","doi-asserted-by":"publisher","first-page":"4398","DOI":"10.1016\/j.vaccine.2015.07.035","article-title":"Safety monitoring in the Vaccine Adverse Event Reporting System (VAERS).","volume":"33","author":"Shimabukuro","year":"2015","journal-title":"Vaccine"},{"key":"key-10.15585\/mmwr.mm7130a4-202207280706-R4","doi-asserted-by":"publisher","first-page":"249","DOI":"10.15585\/mmwr.mm7107e1","article-title":"Safety monitoring of COVID-19 vaccine booster doses among adults\u2014United States, September 22, 2021\u2013February 6, 2022.","volume":"71","author":"Hause","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.15585\/mmwr.mm7130a4-202207280706-R5","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1056\/NEJMc2202542","article-title":"Efficacy of a fourth dose of Covid-19 mRNA vaccine against Omicron.","volume":"386","author":"Regev-Yochay","year":"2022","journal-title":"N Engl J Med"},{"key":"key-10.15585\/mmwr.mm7130a4-202207280706-R6","unstructured":"Gruber WC. BNT162b2 [COMIRNATY (COVID-19 vaccine, mRNA)] booster (third) dose. Presented at the Advisory Committee on Immunization Practices meeting, Atlanta, GA; September 22, 2021. https:\/\/www.cdc.gov\/vaccines\/acip\/meetings\/downloads\/slides-2021-09-22\/02-COVID-Gruber-508.pdf"},{"key":"key-10.15585\/mmwr.mm7130a4-202207280706-R7","unstructured":"Miller J. Safety and immunogenicity of a 50 \u00b5g booster dose of Moderna COVID-19 vaccine. Presented at the Advisory Committee on Immunization Practices meeting, Atlanta, GA; October 21, 2021. https:\/\/www.cdc.gov\/vaccines\/acip\/meetings\/downloads\/slides-2021-10-20-21\/02-COVID-Miller-508.pdf"},{"key":"key-10.15585\/mmwr.mm7130a4-202207280706-R8","doi-asserted-by":"publisher","first-page":"2201","DOI":"10.1001\/jama.2021.5374","article-title":"Reactogenicity following receipt of mRNA-based COVID-19 vaccines.","volume":"325","author":"Chapin-Bardales","year":"2021","journal-title":"JAMA"},{"key":"key-10.15585\/mmwr.mm7130a4-202207280706-R9","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1016\/S1473-3099(22)00054-8","article-title":"Safety of mRNA vaccines administered during the initial 6 months of the US COVID-19 vaccination programme: an observational study of reports to the Vaccine Adverse Event Reporting System and v-safe.","volume":"22","author":"Rosenblum","year":"2022","journal-title":"Lancet Infect Dis"},{"key":"key-10.15585\/mmwr.mm7130a4-202207280706-R10","doi-asserted-by":"publisher","first-page":"931","DOI":"10.15585\/mmwr.mm7129e1","article-title":"Effectiveness of 2, 3, and 4 COVID-19 mRNA vaccine doses among immunocompetent adults during periods when SARS-CoV-2 Omicron BA.1 and BA.2\/BA.2.12.1 sublineages predominated\u2014VISION network, 10 states, December 2021\u2013June 2022.","volume":"71","author":"Link-Gelles","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"}],"container-title":["MMWR. Morbidity and Mortality Weekly Report"],"original-title":[],"deposited":{"date-parts":[[2022,7,28]],"date-time":"2022-07-28T11:11:18Z","timestamp":1659006678000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.cdc.gov\/mmwr\/volumes\/71\/wr\/mm7130a4.htm?s_cid=mm7130a4_w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,29]]},"references-count":10,"journal-issue":{"issue":"30","published-online":{"date-parts":[[2022,7,29]]}},"URL":"https:\/\/doi.org\/10.15585\/mmwr.mm7130a4","relation":{},"ISSN":["0149-2195","1545-861X"],"issn-type":[{"value":"0149-2195","type":"print"},{"value":"1545-861X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,7,29]]},"published":{"date-parts":[[2022,7,29]]}}}